Đang chuẩn bị liên kết để tải về tài liệu:
Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

It has been hypothesized that radiotherapy (RT) techniques delivering radiations to larger volumes (IMRT, VMAT) are potentially associated with a higher risk of second primary tumors. | Radiotherapy of prostate cancer impact of treatment characteristics on the incidence of second tumors

TÀI LIỆU LIÊN QUAN

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy

Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: A meta-analysis of randomized controlled trials

Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): Study protocol

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): Study protocol for a randomised phase III trial

Oligometastases from prostate cancer: Local treatment with stereotactic body radiotherapy (SBRT)

Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo

Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”

Intensity-modulated radiotherapy versus radical prostatectomy in patients with localized prostate cancer: Long-term follow-up

Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensitymodulated radiotherapy for clinically localized prostate cancer
crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.